CHEK2 and lobular breast carcinoma in situ: Data on pure LCIS is very limited, but previous research involving cases from the GLACIER study has shown an association between pathogenic germline mutations in the CHEK2 gene and increased risk of LCIS, although this mutation was rare (3% of LCIS cases) [53].